These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 26518708)

  • 21. PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.
    Riva G; Pecorari G; Biolatti M; Pautasso S; Lo Cigno I; Garzaro M; Dell'Oste V; Landolfo S
    Mol Biol Rep; 2019 Jun; 46(3):3333-3347. PubMed ID: 30980272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating Cell-Free SEPT9 DNA Methylation in Blood Is a Biomarker for Minimal Residual Disease Detection in Head and Neck Squamous Cell Carcinoma Patients.
    Dietrich D; Weider S; de Vos L; Vogt TJ; Färber M; Zarbl R; Hunecke A; Glosch AK; Gabrielpillai J; Bootz F; Bauernfeind FG; Kramer FJ; Kristiansen G; Brossart P; Strieth S; Franzen A
    Clin Chem; 2023 Sep; 69(9):1050-1061. PubMed ID: 37477541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of DNA methylation in head and neck squamous cell carcinoma indicates differences by survival and clinicopathologic characteristics.
    Colacino JA; Dolinoy DC; Duffy SA; Sartor MA; Chepeha DB; Bradford CR; McHugh JB; Patel DA; Virani S; Walline HM; Bellile E; Terrell JE; Stoerker JA; Taylor JM; Carey TE; Wolf GT; Rozek LS
    PLoS One; 2013; 8(1):e54742. PubMed ID: 23358896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of gene methylation in human papillomavirus associated-head and neck squamous cell carcinoma.
    Zhang HZ; Shan CG; Huang AP; Wang JM
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment.
    Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid Capture 2 human papillomavirus testing of fine needle aspiration cytology of head and neck squamous cell carcinomas.
    Hakima L; Adler E; Prystowsky M; Schiff B; Schlecht N; Fox A; Suhrland M; Khader SN
    Diagn Cytopathol; 2015 Sep; 43(9):683-7. PubMed ID: 25964135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter Hypermethylation Profiling Identifies Subtypes of Head and Neck Cancer with Distinct Viral, Environmental, Genetic and Survival Characteristics.
    Choudhury JH; Ghosh SK
    PLoS One; 2015; 10(6):e0129808. PubMed ID: 26098903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients.
    Goltz D; Gevensleben H; Dietrich J; Schroeck F; de Vos L; Droege F; Kristiansen G; Schroeck A; Landsberg J; Bootz F; Dietrich D
    Oncotarget; 2017 Jun; 8(25):41011-41020. PubMed ID: 28487502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of HPV in head and neck squamous cell carcinoma.
    Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
    Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Unique DNA methylation signature in HPV-positive head and neck squamous cell carcinomas.
    Degli Esposti D; Sklias A; Lima SC; Beghelli-de la Forest Divonne S; Cahais V; Fernandez-Jimenez N; Cros MP; Ecsedi S; Cuenin C; Bouaoun L; Byrnes G; Accardi R; Sudaka A; Giordanengo V; Hernandez-Vargas H; Pinto LF; Van Obberghen-Schilling E; Herceg Z
    Genome Med; 2017 Apr; 9(1):33. PubMed ID: 28381277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.
    Masterson L; Winder DM; Ball SL; Vaughan K; Lehmann M; Scholtz LU; Sterling JC; Sudhoff HH; Goon PK
    BMC Cancer; 2016 Jun; 16():367. PubMed ID: 27296171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of E-cadherin is an independent predictor of improved survival in head and neck squamous cell carcinoma.
    Marsit CJ; Posner MR; McClean MD; Kelsey KT
    Cancer; 2008 Oct; 113(7):1566-71. PubMed ID: 18711702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas.
    Bennett KL; Lee W; Lamarre E; Zhang X; Seth R; Scharpf J; Hunt J; Eng C
    Genes Chromosomes Cancer; 2010 Apr; 49(4):319-26. PubMed ID: 20029986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA methylation derived systemic inflammation indices are associated with head and neck cancer development and survival.
    Ambatipudi S; Langdon R; Richmond RC; Suderman M; Koestler DC; Kelsey KT; Kazmi N; Penfold C; Ho KM; McArdle W; Ring SM; Pring M; Waterboer T; Pawlita M; Gaunt TR; Davey Smith G; Thomas S; Ness AR; Relton CL
    Oral Oncol; 2018 Oct; 85():87-94. PubMed ID: 30220325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique DNA methylation loci distinguish anatomic site and HPV status in head and neck squamous cell carcinoma.
    Lleras RA; Smith RV; Adrien LR; Schlecht NF; Burk RD; Harris TM; Childs G; Prystowsky MB; Belbin TJ
    Clin Cancer Res; 2013 Oct; 19(19):5444-55. PubMed ID: 23894057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free-Circulating Methylated DNA in Blood for Diagnosis, Staging, Prognosis, and Monitoring of Head and Neck Squamous Cell Carcinoma Patients: An Observational Prospective Cohort Study.
    Schröck A; Leisse A; de Vos L; Gevensleben H; Dröge F; Franzen A; Wachendörfer M; Schröck F; Ellinger J; Teschke M; Wilhelm-Buchstab T; Landsberg J; Holdenrieder S; Hartmann G; Field JK; Bootz F; Kristiansen G; Dietrich D
    Clin Chem; 2017 Jul; 63(7):1288-1296. PubMed ID: 28515105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
    Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
    J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.